Company Name: Chiasma Inc.  

Chiasma Inc. is a late-stage biopharmaceutical company. The company is engaged in the development of oral therapies designed to treat orphan diseases using its proprietary Transient Permeability Enhancer technology platform. The company’s lead product candidate is designed to treat acromegaly.

Ticker Symbol: CHMA (NASDAQ)

Company Website: www.chiasmapharma.com

Social Media: Chiasma LinkedIn

Headquarters: Newton, MA